Neptune Wellness Solutions Inc trades with the ticker NEPT on the TSX and is in the Drug Manufacturers – Specialty & Generic industry.
Overview
Neptune Wellness Solutions Inc. operates as an integrated health and wellness company in Canada, the United States, and internationally. It builds a portfolio of lifestyle brands and consumer packaged goods products under the Biodroga, Forest Remedies, Ocean Remedies, Neptune Wellness, Mood Ring, PanHash, Sprout, Nosh, MaxSimil, and NurturMe brands. The company also offers turnkey product development and supply chain solutions to business customers in various health and wellness verticals, including nutraceuticals, beauty and personal care products, and organic foods and beverages. In addition, it is involved in the extraction, purification, formulation, and manufacturing of health and wellness products. Further, the company offers Maxsimil, an omega-3 fatty acid delivery technology that uses enzymes that mimic the natural human digestive system to predigest omega-3 fatty acids. It has a collaboration agreement with International Flavors & Fragrances Inc. to co-develop hemp-derived CBD products for the mass retail, and health and wellness markets. The company was incorporated in 1998 and is headquartered in Laval, Canada.
Looking to invest in Neptune Wellness Solutions Inc? Our analysis brings in the key facts, competitor research and valuation metrics for you to make an informed decision.
Table of Contents
show
NEPT.TO Stock Price and Key Stats
ETF Key Stats
Exchange: TSX
Market Cap : $15.735MM
PE Ratio:
Price: #N/A (Updated: 3/12/2024 0:47:16)
Neptune Wellness Solutions Inc (NEPT) vs Competitors in Drug Manufacturers – Specialty & Generic
Lets see how NEPT.TO stacks up against others in the Drug Manufacturers – Specialty & Generic asset management industry. We have identified its main peers as:Aleafia Health Inc, Aphria Inc, Acerus Pharmaceuticals Corporation, Correvio Pharma Corp, The Supreme Cannabis Company, Inc
.Drug Manufacturers – Specialty & Generic Industry Comparisons
| Company | Market Cap ($MM) | P/E Ratio | EV/EBITDA | Dividend Yield |
|---|---|---|---|---|
| Aleafia Health Inc (ALEF) | $189.563 | N/A | 0.0 | 0.0% |
| Aphria Inc (APHA) | $4,439.753 | N/A | 598.009 | 0.0% |
| Acerus Pharmaceuticals Corporation (ASP) | $2.775 | N/A | -2.796 | 0.0% |
| Correvio Pharma Corp (CORV) | $37.067 | N/A | 0.0 | 0.0% |
| The Supreme Cannabis Company, Inc (FIRE) | $255.583 | N/A | 0.0 | 0.0% |
EV/EBITDA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation, and Amortization – this ratio compares the value of a company, including debt, to the company’s cash earnings less non-cash expenses
Industry: companies that have a lot in common
Market Cap: Market Capitalization – the total value of all a corporation’s stock
N/A: Not Applicable or Not Available
P/E: Price-to-Earnings – this ratio relates a corporation’s share price to its earnings per share
Price: Stock Price – current value to buyers and sellers
Dividend Yield: Dividend or Distribution Yield
Comparisons within Drug Manufacturers – Specialty & Generic
- Neptune Wellness Solutions Inc (NEPT) vs Aleafia Health Inc (ALEF)
- ALEF has higher EPS (-0.274 vs -24.158). ALEF has higher dividend yield (0.0% vs 0.0%). ALEF and NEPT both have P/E’s under 0.
- Neptune Wellness Solutions Inc (NEPT) vs Aphria Inc (APHA)
- APHA has higher EPS (0.116 vs -24.158). APHA has higher dividend yield (0.0% vs 0.0%). APHA and NEPT both have P/E’s under 0.
- Neptune Wellness Solutions Inc (NEPT) vs Acerus Pharmaceuticals Corporation (ASP)
- ASP has higher EPS (-4.41 vs -24.158). ASP has higher dividend yield (0.0% vs 0.0%). ASP and NEPT both have P/E’s under 0.
- Neptune Wellness Solutions Inc (NEPT) vs Correvio Pharma Corp (CORV)
- CORV has higher EPS (-0.879 vs -24.158). CORV has higher dividend yield (0.0% vs 0.0%). CORV and NEPT both have P/E’s under 0.
- Neptune Wellness Solutions Inc (NEPT) vs The Supreme Cannabis Company, Inc (FIRE)
- FIRE has higher EPS (-0.052 vs -24.158). FIRE has higher dividend yield (0.0% vs 0.0%). FIRE and NEPT both have P/E’s under 0.
Our Recommendation: Hold
Shows positive EPS growth from this year to next, suggesting improving profitability. Features a lower EV/EBITDA ratio (0.25) than the industry average (2.71), indicating attractive valuation.
How to Buy NEPT stock on the TSX
You can buy on pretty much any online brokerage in Canada, since it trades on the TSX. If you are looking for some easy options take a look at these two:| Image | Product Title | Features | Price |
|---|---|---|---|
Editor's Choice  |
| Get $25 Signup Bonus | |
Reliable Pick  |
| Get $50 Free Stock Trades |
